These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4044874)

  • 1. Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia.
    Wheat PF; Winstanley TG; Spencer RC
    J Clin Pathol; 1985 Sep; 38(9):1055-8. PubMed ID: 4044874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of temperature on antimicrobial susceptibilities of Pseudomonas species isolated from drinking water.
    Papapetropoulou M; Rodopoulou G; Giannoulaki E; Stergiopoulos P
    J Chemother; 1994 Dec; 6(6):404-7. PubMed ID: 7699428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibilities of Pseudomonas species to aminoglycosides and tetracyclines].
    Igari J; Kosakai N; Oguri T
    Jpn J Antibiot; 1982 May; 35(5):1233-9. PubMed ID: 7131756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.
    Felegie TP; Yu VL; Rumans LW; Yee RB
    Antimicrob Agents Chemother; 1979 Dec; 16(6):833-7. PubMed ID: 533264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents.
    Khardori N; Reuben A; Rosenbaum B; Rolston K; Bodey GP
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1609-10. PubMed ID: 2221872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B Etest
    Kulengowski B; Ribes JA; Burgess DS
    Clin Microbiol Infect; 2019 Jan; 25(1):92-95. PubMed ID: 29674129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of antimicrobials against
    Spierer O; Miller D; O'Brien TP
    Br J Ophthalmol; 2018 May; 102(5):708-712. PubMed ID: 29459431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime aminoglycoside interactions.
    Pierce MA; Elliott AM; Cobbs CG
    Chemotherapy; 1985; 31(5):336-45. PubMed ID: 4053733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
    Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G
    Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing strategy based on prevailing aminoglycoside minimum inhibitory concentration in India: Evidence and issues.
    Veeraraghavan B; Pragasam AK; Manesh A; Rupali P; Iyadurai R; Rodrigues C; Joshi S; Roy I; Chaudhuri BN; Chitnis DS; Tapan D
    Indian J Med Microbiol; 2017; 35(4):585-587. PubMed ID: 29405154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used.
    Busch-Sørensen C; Sönmezoglu M; Frimodt-Møller N; Højbjerg T; Miller GH; Espersen F
    APMIS; 1996 Oct; 104(10):763-8. PubMed ID: 8980628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Pseudomonas maltophilia to antimicrobial agents.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1986 Jan; 39(1):121-6. PubMed ID: 3702054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms.
    Tacão M; Correia A; Henriques IS
    Microb Drug Resist; 2015 Oct; 21(5):497-506. PubMed ID: 26430939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of fluoroquinolones, aminoglycosides, ureidopenicillins & newer cephalosporins against Pseudomonas species.
    Paul K; De PK; Bhattacharya S
    Indian J Med Res; 1992 May; 95():136-8. PubMed ID: 1506063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.